Mumbai, August 01: The Initial Public Offering of Manipal Health Enterprises Limited was subscribed 4.92 times on the final day of bidding.
The issue received bids of 44,30,73,025 equity shares against the offered 9,00,88,286 equity shares, according to data available on the stock exchanges.
Qualified Institutional Buyers (QIB) and Retail Portion were subscribed 8.25 times and 0.93 times, respectively. Non-Institutional Investors (NII) portion was subscribed 1.02 times whereas the employee reserved portion subscribed 2.19 times.
IPO Details
The IPO is a fresh issue of up to Rs 8,000 crore, and an offer-for-sale of up to 21,613,834 equity shares by promoters – Imperius Healthcare Investments Pte. Ltd, and Manipal Education and Medical Group India Private Limited.
Investors selling shares include TPG SG Magazine Pte. Ltd, Seventy Second Investment Company LLC, Ammar Sdn Bhd, Novo Holdings Invest Asia A/S and Phoenix Bear Investments, LLC.
The proceeds from its fresh issuance worth Rs 5,552.7 crore will be utilised for repayment/ prepayment, in full or in part, of certain outstanding borrowings and accrued interest thereon availed by one of the company’s material subsidiaries, Manipal Hospitals Private Limited, Rs 574 crore for acquisition of minority stake in the company’s step-down subsidiary, Sahyadri Hospitals Private Limited, and general corporate purposes.
Investors can bid for a minimum of 25 Equity Shares and in multiples of 25 Equity Shares thereafter.
Company Information
The company operates a pan-India network of multispecialty hospitals delivering a comprehensive range of care services—from outpatient services to complex tertiary and quaternary interventions. As of March 31, 2026, the company operated 49 hospitals with 13,037 licensed beds across 14 states and union territories.
The company has the widest footprint in terms of presence of hospitals among private hospital chains in India as of March 31, 2026 (Source: CRISIL Report). It is the largest pan-India multispecialty hospital network by bed capacity and the second-largest hospital chain by number of hospitals as of March 31, 2026 (Source: CRISIL Report).
For Fiscal 2026, the company reported the second-highest revenue from operations of ₹103,297.51 million (₹109,336.34 million on a pro forma basis) among private hospital chains in India (Source: CRISIL Report).
In its three key regions of Karnataka, Maharashtra and Goa and West Bengal, Odisha, Jharkhand, and Sikkim, the company had 6,404, 2,188 and 2,887 licensed beds, respectively, as of March 31, 2026.